Christopher E. Pelloski

6.4k citations

35 papers · 2.2k indexed · h-index 17

Impact in

Genetics top 1%
- Glioma Diagnosis and Treatment
Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Radiation 7
- Advanced Radiotherapy Techniques 7
Genetics 7
- Glioma Diagnosis and Treatment 7

Co-authors: Kenneth Aldape (8 shared papers)Howard Colman (7 shared papers)Mark R. Gilbert (4 shared papers)Erik P. Sulman (5 shared papers)Alicia Rivera (2 shared papers)B. Nebiyou Bekele (2 shared papers)C. Cruz (1 shared paper)Dima Suki (3 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (7 papers)Cancer Research (6 papers)Clinical Cancer Research (3 papers)Neuro-Oncology (3 papers)Pediatric Blood & Cancer (2 papers)
Partner nations: United States South Korea Canada

In The Last Decade

Christopher E. Pelloski

34 papers receiving 2.2k citations

Peers

Countries citing papers authored by Christopher E. Pelloski

Since Specialization

Citations

This map shows the geographic impact of Christopher E. Pelloski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Pelloski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Pelloski more than expected).

Fields of papers citing papers by Christopher E. Pelloski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Pelloski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Pelloski. The network helps show where Christopher E. Pelloski may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher E. Pelloski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher E. Pelloski Line = papers co-authored together Christopher E. Pelloski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma Neuro-Oncology ·Alicia Rivera, Christopher E. Pelloski, Mark R. Gilbert, Howard Colman, C. Cruz, Erik P. Sulman, B. Nebiyou Bekele, Kenneth Aldape	2009	319
2	A multigene predictor of outcome in glioblastoma Neuro-Oncology ·Howard Colman, Lin Zhang, Erik P. Sulman, J. Matthew McDonald, N. L. Shooshtari, Alicia Rivera, Steven N. Popoff, Catherine L. Nutt, David N. Louis, J. Gregory Cairncross, Mark R. Gilbert, Heidi Phillips, Minesh P. Mehta, Arnab Chakravarti, Christopher E. Pelloski, Kruttika Bhat, Burt G. Feuerstein, Robert B. Jenkins, K. Aldape	2009	285
3	FoxM1B Is Overexpressed in Human Glioblastomas and Critically Regulates the Tumorigenicity of Glioma Cells Cancer Research ·Mingguang Liu, Bingbing Dai, Shin-Hyuk Kang, Kechen Ban, Feng-Ju Huang, Frederick F. Lang, Kenneth Aldape, Tongxin Xie, Christopher E. Pelloski, Keping Xie, Raymond Sawaya, Suyun Huang	2006	272
4	Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma Journal of Clinical Oncology ·Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Li Zhang, E. Lin, Erik P. Sulman, Krishna Bhat, J. Matthew McDonald, W.K. Alfred Yung, Howard Colman, Shiao Y. Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, Fred G. Barker, Jan C. Buckner, C. David James, Kenneth Aldape	2007	239
5	YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma Clinical Cancer Research ·Christopher E. Pelloski, Anita Mahajan, Moshe Maor, Eric L. Chang, Shiao Y. Woo, Mark R. Gilbert, Howard Colman, Helen Yang, Alicia A. Ledoux, Hilary Blair, Sandra Passe, Robert B. Jenkins, Kenneth Aldape	2005	170
6	Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma Clinical Cancer Research ·Christopher E. Pelloski, Ethan Lin, Li Zhang, W.K. Alfred Yung, Howard Colman, Juinn-Lin Liu, Shaio Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, F. G. Barker, Gregory N. Fuller, Kenneth Aldape	2006	163
7	Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer International Journal of Radiation OncologyBiologyPhysics ·Christopher E. Pelloski, Matthew Palmer, Gregory M. Chronowski, Anuja Jhingran, John L. Horton, Patricia J. Eifel	2005	117
8	Assessment and Prognostic Significance of Mitotic Index Using the Mitosis Marker Phospho-histone H3 in Low and Intermediate-grade Infiltrating Astrocytomas The American Journal of Surgical Pathology ·Howard Colman, Caterina Giannini, Li Huang, Javier Gonzalez, Kenneth R. Hess, Janet Bruner, Gregory N. Fuller, Lauren A. Langford, Christopher E. Pelloski, Joann Aaron, Peter C. Burger, Ken Aldape	2006	114
9	Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications Journal of neurosurgery ·Brian J. Williams, Dima Suki, Benjamin D. Fox, Christopher E. Pelloski, Marcos Vinícius Calfat Maldaun, Raymond Sawaya, Frederick F. Lang, Ganesh Rao	2009	94
10	Management of complex breast cysts. American Journal of Roentgenology ·Luz A. Venta, J P Kim, Christopher E. Pelloski, Monica Morrow	1999	76
11	Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks Cancer Research ·Changxian Shen, Duane Oswald, Doris A. Phelps, Hakan Çam, Christopher E. Pelloski, Qishen Pang, Peter J. Houghton	2013	74
12	Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort Pediatric Blood & Cancer ·Anita Mahajan, Shiao Y. Woo, David Kornguth, Dennis P.M. Hughes, Winston W. Huh, Eric L. Chang, Cynthia E. Herzog, Christopher E. Pelloski, Pete Anderson	2008	49
13	Selective repression of YKL‐40 by NF‐κB in glioma cell lines involves recruitment of histone deacetylase‐1 and ‐2 FEBS Letters ·Krishna Bhat, Christopher E. Pelloski, Yujian Zhang, Se Hoon Kim, Clarissa deLaCruz, Michael Rehli, Kenneth Aldape	2008	40
14	Clinical stage IEA–IIEA orbital lymphomas: outcomes in the era of modern staging and treatment Radiotherapy and Oncology ·Christopher E. Pelloski, Richard B. Wilder, Chul S Ha, Mark A. Hess, Fernando Cabanillas, James D. Cox	2001	39
15	Cytomegalovirus Infection Leads to Pleomorphic Rhabdomyosarcomas in Trp53 +/− Mice Cancer Research ·Richard L. Price, Katherine Bingmer, Lualhati Harkins, O. Hans Iwenofu, Chang-Hyuk Kwon, Charles H. Cook, Christopher E. Pelloski, E. Antonio Chiocca	2012	38
16	Optimal Treatment Planning for Skull Base Chordoma: Photons, Protons, or a Combination of Both? International Journal of Radiation OncologyBiologyPhysics ·Mylin A. Torres, Eric L. Chang, Anita Mahajan, David G. Lege, Beverly A. Riley, Xiaodong Zhang, MingFwu Lii, David Kornguth, Christopher E. Pelloski, Shiao Y. Woo	2009	34
17	Elevated Phospho-S6 Expression Is Associated with Metastasis in Adenocarcinoma of the Lung Clinical Cancer Research ·J. Matthew McDonald, Christopher E. Pelloski, Alicia A. Ledoux, Menghong Sun, Gabriela Raso, Ritsuko Komaki, Ignacio I. Wistuba, B. Nebiyou Bekele, Ken Aldape	2008	29
18	Prognostic and Predictive Markers in Glioma and Other Neuroepithelial Tumors Current Problems in Cancer ·Andreana L. Rivera, Christopher E. Pelloski, Erik P. Sulman, Ken Aldape	2008	11
19	Using NanoDot dosimetry to study the RS 2000 X-ray Biological Irradiator International Journal of Radiation Biology ·Lanchun Lu, Kathryn Bondra, Nilendu Gupta, J. Sommerfeld, Christopher Chronowski, J. Leigh Leasure, Mamata Singh, Christopher E. Pelloski	2013	11
20	A three-dimensional computed tomography–assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer International Journal of Radiation OncologyBiologyPhysics ·Kent A. Gifford, John L. Horton, Christopher E. Pelloski, Anuja Jhingran, Laurence E. Court, Firas Mourtada, Patricia J. Eifel	2005	11

About Christopher E. Pelloski

Christopher E. Pelloski is a scholar working on Radiation, Genetics, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (7 papers), Glioma Diagnosis and Treatment (7 papers), Studies on Chitinases and Chitosanases (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Peptidase Inhibition and Analysis (4 papers), MicroRNA in disease regulation (3 papers), Management of metastatic bone disease (3 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Genetics (847 citations), Cancer Research (540 citations), Oncology (532 citations), Molecular Biology (1.1k citations) and Obstetrics and Gynecology (120 citations). Christopher E. Pelloski has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Kenneth Aldape, Howard Colman, Mark R. Gilbert, Erik P. Sulman, Alicia Rivera, B. Nebiyou Bekele, C. Cruz, Dima Suki, Shiao Y. Woo and Raymond Sawaya. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer Research, Clinical Cancer Research, Neuro-Oncology and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact